Please check your internet connection and try again.
# Sompraz HP (Pantoprazole Sodium)
## Overview
Sompraz HP is a combination product containing pantoprazole sodium and amoxicillin and clarithromycin, intended for the eradication of *Helicobacter pylori* infection in patients with active peptic ulcer disease or a history of peptic ulcer disease. Pantoprazole is a proton pump inhibitor (PPI).
## Primary Indications
* Eradication of *Helicobacter pylori* infection in patients with active duodenal ulcer or gastric ulcer disease.
## Adult Dosing
The standard regimen for adults is:
* Pantoprazole 40 mg orally once daily for 7 days (taken in the morning).
* Amoxicillin 1000 mg orally twice daily for 7 days.
* Clarithromycin 500 mg orally twice daily for 7 days.
## Pediatric Dosing
There is **no established pediatric dosing** for Sompraz HP. The components of the combination product (pantoprazole, amoxicillin, clarithromycin) have specific pediatric dosing recommendations for other indications, but this specific combination is not typically studied or recommended in pediatric populations.
## Dose Adjustments
No specific dose adjustments are typically required for patients with renal or hepatic impairment, though caution and clinical judgment are advised, particularly in severe hepatic impairment for pantoprazole.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, other macrolides, or penicillins.
* History of severe hypersensitivity reactions to other beta-lactam antibiotics.
* Concomitant use with rilpivirine.
* Patients with a history of cholestatic jaundice/hepatic dysfunction from prior clarithromycin exposure.
## Adverse Effects
Common adverse effects may include:
* **Gastrointestinal:** Diarrhea, nausea, abdominal pain, vomiting, taste perversion, dry mouth.
* **Infections:** Fungal infections.
* **Nervous System:** Headache, dizziness.
* **Allergic Reactions:** Rash, urticaria.
* **Other:** Elevated liver enzymes.
## Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs where gastric pH influences bioavailability (e.g., ketoconazole, itraconazole, digoxin, certain HIV medications like atazanavir and nelfinavir). May increase the risk of *Clostridium difficile*-associated diarrhea.
* **Clarithromycin:** Potent CYP3A4 inhibitor. Can increase serum concentrations of numerous drugs metabolized by CYP3A4, including statins, certain calcium channel blockers, anticoagulants (e.g., warfarin), and colchicine, potentially leading to toxicity. Avoid with colchicine if the patient has renal or hepatic impairment.
* **Amoxicillin:** May decrease the effectiveness of oral contraceptives.
## Monitoring
* Monitor for signs of hypersensitivity reactions.
* Assess for resolution of *H. pylori* infection typically 4-6 weeks after completing therapy via a stool antigen test or urea breath test.
* Monitor for signs and symptoms of *Clostridium difficile*-associated diarrhea.
* Monitor for potential drug interactions, especially with clarithromycin.
## Clinical Pearls
* This is a 7-day regimen. Compliance is crucial for eradication.
* Take pantoprazole in the morning before breakfast. Take amoxicillin and clarithromycin with meals to minimize gastrointestinal upset.
* If a patient has a penicillin allergy, alternative *H. pylori* eradication regimens should be considered.
* Ensure adequate hydration.
* The efficacy of this regimen may be affected by local antibiotic resistance patterns.
---
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details. Dosing and treatment decisions should be individualized based on patient-specific factors and local protocols.*
